BR0314364A - Uso de inibidores de pde iv para tratar angiogênese - Google Patents

Uso de inibidores de pde iv para tratar angiogênese

Info

Publication number
BR0314364A
BR0314364A BR0314364-3A BR0314364A BR0314364A BR 0314364 A BR0314364 A BR 0314364A BR 0314364 A BR0314364 A BR 0314364A BR 0314364 A BR0314364 A BR 0314364A
Authority
BR
Brazil
Prior art keywords
pde inhibitors
treat angiogenesis
inhibitors
pde
angiogenesis
Prior art date
Application number
BR0314364-3A
Other languages
English (en)
Inventor
Daniel A Gamache
David P Bingaman
Michael A Kapin
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Publication of BR0314364A publication Critical patent/BR0314364A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

"USO DE INIBIDORES DE PDE IV PARA TRATAR ANGIOGêNESE". A presente invenção refere-se a inibidores de PDE-IV seletivos que são úteis para a prevenção e tratamento de distúrbios e doenças relacionados com edema/angiogênicos.
BR0314364-3A 2002-09-16 2003-09-11 Uso de inibidores de pde iv para tratar angiogênese BR0314364A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41100102P 2002-09-16 2002-09-16
PCT/US2003/028675 WO2004024085A2 (en) 2002-09-16 2003-09-11 Use of pde iv inhibitors to treat angiogenesis

Publications (1)

Publication Number Publication Date
BR0314364A true BR0314364A (pt) 2005-07-19

Family

ID=31994234

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314364-3A BR0314364A (pt) 2002-09-16 2003-09-11 Uso de inibidores de pde iv para tratar angiogênese

Country Status (14)

Country Link
US (3) US20040053939A1 (pt)
EP (1) EP1539174A4 (pt)
JP (1) JP2006501269A (pt)
KR (1) KR20050043923A (pt)
CN (1) CN1681510A (pt)
AR (1) AR041263A1 (pt)
AU (1) AU2003267161A1 (pt)
BR (1) BR0314364A (pt)
CA (1) CA2497192A1 (pt)
MX (1) MXPA05002146A (pt)
PL (1) PL374659A1 (pt)
TW (1) TW200412972A (pt)
WO (1) WO2004024085A2 (pt)
ZA (1) ZA200501477B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851247B1 (fr) 2003-02-19 2007-06-29 Exonhit Therapeutics Sa Methodes et compositions pour le traitement de pathologies degeneratives oculaires
PL1755616T3 (pl) * 2004-04-08 2014-10-31 Eye Co Pty Ltd Leczenie mineralokortykoidami retinopatii wysiękowej
NZ568694A (en) 2005-11-09 2011-09-30 Zalicus Inc Method, compositions, and kits for the treatment of medical conditions
PL2117524T3 (pl) * 2007-01-29 2020-03-31 National Research Council Of Canada Zastosowanie katecholamin i pokrewnych związków jako środków przeciwangiogennych

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570579B1 (fr) * 1984-09-26 1987-01-09 Salomon Sa Dispositif de fermeture et de serrage d'une chaussure de ski a ouverture arriere
US4975537A (en) * 1985-10-23 1990-12-04 The Upjohn Company Δ9(11) -angiostatic steroids
US4771042A (en) * 1985-11-25 1988-09-13 The Upjohn Company Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
US5605914A (en) * 1993-07-02 1997-02-25 Celgene Corporation Imides
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
US6333354B1 (en) * 1997-02-28 2001-12-25 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
US5866872A (en) * 1997-07-25 1999-02-02 Hypertherm, Inc. Plasma arc torch position control
DE19812515A1 (de) * 1998-03-21 1999-09-23 M & F Entw & Patentverwertungs Lamellenschleifwerkzeug
TR200200971T2 (tr) * 1998-09-29 2002-06-21 Fujisawa Pharmaceutical Co., Ltd. Piridopirazan bileşiğinin yeni tuzları ve bunların kristalleri.
US6740664B2 (en) * 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
US6326888B1 (en) * 1998-12-17 2001-12-04 Ching-Yung Wang Auxiliary safety warning light system for a vehicle
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis

Also Published As

Publication number Publication date
WO2004024085A3 (en) 2004-04-29
US20050277648A1 (en) 2005-12-15
ZA200501477B (en) 2006-10-25
AR041263A1 (es) 2005-05-11
JP2006501269A (ja) 2006-01-12
TW200412972A (en) 2004-08-01
US20060014782A1 (en) 2006-01-19
CN1681510A (zh) 2005-10-12
KR20050043923A (ko) 2005-05-11
EP1539174A4 (en) 2006-10-25
EP1539174A2 (en) 2005-06-15
MXPA05002146A (es) 2005-05-23
CA2497192A1 (en) 2004-03-25
AU2003267161A1 (en) 2004-04-30
PL374659A1 (en) 2005-10-31
WO2004024085A2 (en) 2004-03-25
US20040053939A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
UY26130A1 (es) Compuestos para tratar la obesidad
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
NO20034056D0 (no) Proliferative sykdommer
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
SE9703693D0 (sv) Novel combination
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
TR200401545T4 (tr) NOSS inhibitörü ilaçların amalatı için ikame imidazo [1,2-a]piridin-,-pirimidin- ve-pirazin-3-amin-türevlerinin kullanımı
BR0114913A (pt) Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
BRPI0510094A (pt) uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos
WO2003106381A3 (en) ADAM 10 HUMAN INHIBITORS
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
ECSP045156A (es) Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6
CY1119190T1 (el) Χρηση αναστολεων της il-18 για αγωγη ή προληψη βλαβων του κνς
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
BR0111892A (pt) Bis-arilsulfonas
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
BRPI0508333A (pt) uso de um composto de vitamina d, método de prevenir e/ou tratar cistite intersticial, formulação farmacêutica, composto de vitamina d, e, kit
ATE439363T1 (de) Imidazo 2,1-b -1,3,4-thiadiazole sulfonamides
BR0311903A (pt) Tratamento para depressão e ansiedade pela combinação de um inibidor de pde iv e um agente antidepressivo ou ansiolìtico
BR0008603A (pt) Método para tratamento de copd
BR0314364A (pt) Uso de inibidores de pde iv para tratar angiogênese
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
BR0011363A (pt) Quimera il6ril6 para o tratamento de doenças neurodegenerativas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.